Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease

Technology appraisal guidance
Reference number: TA223
Published: 25 May 2011

Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate: final appraisal determination document

Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate: final appraisal determination document

Peripheral arterial disease - cilostazol, naftidrofyryl oxalate, pentoxifylline and inositol nicotinate: final appraisal determination document
14 April 2011
(281.04 Kb 21 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 12 April 2011